Description
Gastric cancer is a leading cause of cancer-related death, claiming more than 1 million lives annually. A major predisposing factor to developing gastric cancer is infection with the bacterium Helicobacter pylori (H. pylori), which interacts with cells of the stomach to establish chronic inflammation.
In parallel, cancer-causing mutations have the potential to give cells in the stomach various advantages over non-cancerous cells, allowing them to readily form tumours and in some instances, evade standard-of-care cancer treatments. However, the intersection of H. pylori infection and known cancer-causing mutations is poorly described and highlights an urgent need to better understand how these two predisposing factors interact. You will investigate how H. pylori infection influences the behaviour and identity of cancer cells in the stomach, with the ambition of developing new therapies that overcome drug-resistance and better patient outcomes.
You will use mouse models of H.pylori infection, microscopy, molecular biology and 3D organoid culture.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
H. pylori, Host-pathogen, Infection, Stem Cells, Stomach, Cancer, Organoids
School
Biomedicine Discovery Institute (School of Biomedical Sciences) » Biochemistry and Molecular Biology
Available options
PhD/Doctorate
Masters by research
Honours
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Clayton Campus